Apricus Biosciences (APRI) in Focus: Stock Gains 10.1% - Tale of the Tape

Apricus Biosciences, Inc. ( APRI ) was a big mover last session, as the company saw its shares rise over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $1.59 to $1.75 in the past one-month time frame.

The company has seen no estimate revision over the past 30 days, while the Zacks Consensus Estimate hasn't been in a trend either. Thursday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Apricus currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

A better-ranked stock in the same space is Cardiome Pharma Corp. ( CRME ) sporting a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

APPRICUS BIOSCI (APRI): Free Stock Analysis Report

CARDIOME PHARMA (CRME): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.